Advancing the Diagnostic-to-Treatment Continuum in Cancer Care

Advancing Precision Medicine | Advancing Pathology Education | Advancing Precision Oncology is a national educational initiative bringing together experts in pathology, oncology, and translational science to share the latest advances shaping patient care. Through a series of free, CME-accredited regional conferences, we connect discovery and clinical practice—bridging diagnostics, data, and therapy to improve outcomes for patients with cancer.

Explore the continuum of care where diagnosis meets treatment.
Find your location today and join the movement advancing precision medicine across the nation.

Why Bringing Pathologists and Oncologists Together Matters

The future of cancer care depends on connection—between discovery and delivery, between the microscope and the clinic, and between the specialists who interpret the disease and those who treat it.

Pathologists and oncologists each hold a vital piece of the patient care puzzle. Pathologists uncover the molecular and cellular signatures of disease, while oncologists translate those findings into targeted treatment plans. When these disciplines work in true partnership, innovation happens faster, diagnoses become more precise, and therapy decisions become more effective and individualized.

In today’s era of precision medicine, this collaboration is no longer optional—it’s essential. Advances in biomarker testing, molecular profiling, AI-enhanced pathology, and targeted therapeutics have blurred the traditional lines between “diagnosis” and “treatment.” Every biomarker result informs therapy selection. Every therapy outcome informs future testing. The cycle of precision care depends on both perspectives working hand in hand.

That’s why our Advancing the Diagnostic-to-Treatment Continuum in Cancer Care programs bring these voices together in the same room. Each session is designed to foster conversation between the laboratory and the clinic—connecting those who generate the data with those who act on it. Through shared discussion, we bridge gaps, identify challenges, and uncover new ways to improve patient outcomes.

By uniting the expertise of pathologists, oncologists, molecular scientists, and researchers, we accelerate the translation of discovery into real-world care—and move closer to what matters most: delivering the right treatment to the right patient at the right time.

Why Accessible Education Matters

We believe education is the foundation of progress in cancer care. The rapid evolution of diagnostics, biomarkers, and targeted therapies demands continuous learning—and every clinician, regardless of institution or resources, deserves access to the latest advances.

That’s why all Advancing Precision Medicine | Advancing Pathology Education | Advancing Precision Oncology programs are free to attend and offer complimentary CE/CME and MOC credits. Our mission is to remove barriers, promote equitable access to high-quality education, and ensure that knowledge reaches every corner of the healthcare community.

By keeping these events accessible, we empower busy professionals—from academic specialists to community practitioners—to stay current with emerging science and immediately apply what they learn to patient care.

Education changes practice. Practice changes outcomes. Together, we’re shaping a smarter, more connected future for precision medicine—one conversation, one discovery, and one patient at a time.